What about PCV2? It is endemic in most farms, and vaccination has proven to be a highly effective tool, being used in the majority of farms worldwide.


But we are dealing with a multifactorial disease where environmental conditions, vaccination management, density, and especially genetics play a very important role. Let’s find out more on PCV2.

Videos & Publications about PCV2

  • The aim of this publication was to show the effect of Mhyosphere® PCV ID vaccination in growth performance of vaccinated pigs.

  • In the following video, we will see the efficacy evaluation of Mhyosphere® PCV ID under field conditions, in terms of lung lesion and reduction of PCV2 viremia.

  • This publication explains the efficacy of Mhyosphere® PCV ID in terms of duration of immunity.

  • In the following video, we will see the efficacy in terms of onset of immunity of Mhyosphere® PCV ID.

  • MHYOSPHERE® PCV ID is the first and only vaccine based on a recombinant Mycoplasama hyopneumoniae (M. hyo) strain, called Nexyhon. This strain expresses the capsid proteins of Por

  • Porcine Circovirus type 2 (PCV2) has been an unusual virus ever since its emergence in the productive setting back in the 1990s. Since its discovery, this virus has been observed to be involved in a w

  • Alex Eggen points out in this video the economic impact behind the subclinical presentation of PCV2.

  • Quim Segalés talks about the important economic impact that the arrival of PCV2 vaccines meant to pig production.

  • Vaccines that induce protection against Porcine Circovirus Type 2 (PCV2) and Mycoplasma hyopneumoniae (M.hyo) represent the top 2 of most used vaccines in the swine sector. Unlike